Smith & Nephew plc (SN)
LSE 
Summary
SN Chart
Smith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgery
SNN launches the LYNX COBLATION Laryngeal Wand, combining precise dissection, rapid debulking and hemostasis for airway procedures.
Smith & Nephew: Ongoing Business Progress And A More Attractive Price
Smith & Nephew continues to demonstrate solid business recovery, with robust revenue, profit, and free cash flow growth across all divisions. SNN's 2026 outlook targets 6% underlying revenue growth, 8% organic trading profit growth, and $800 million in free cash flow, with a new $500 million share buyback announced. Completion of the 12-point plan delivered mixed results: revenue growth targets were met, but trading margin fell short, prompting a new 'RISE' strategy with 2028 financial targets.
Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript
Smith & Nephew plc (SNN) Shareholder/Analyst Call Transcript
Smith & Nephew plc (SN) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Smith & Nephew plc ever had a stock split?
Smith & Nephew plc Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Deepak S Nath CEO | LSE Exchange | GB0009223206 ISIN |
| GB Country | 17,818 Employees | 27 Mar 2026 Last Dividend | 16 Dec 2003 Last Split | 16 Nov 1999 IPO Date |
Overview
Smith & Nephew plc is a globally recognized company specializing in the development, manufacture, marketing, and sale of medical devices and services. Founded in 1856 and based in Watford, the United Kingdom, the company operates internationally, catering to the healthcare sector through its three main segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Smith & Nephew's mission is to improve the quality of life for people around the world by providing innovative and effective medical solutions.
Products and Services
Smith & Nephew offers a comprehensive range of medical devices and services across various specializations:
- Knee Implant Products: Designed for knee replacement procedures, these products aim to restore knee function with durable and efficient implants.
- Hip Implants: Focused on revision procedures, these implants are essential for correcting previous surgeries and ensuring longevity and comfort.
- Trauma and Extremities Products: This range includes both internal and external devices crucial for the stabilization of severe fractures, deformity correction procedures, and other reconstruction needs.
- Sports Medicine Joint Repair: Comprising instruments, technologies, and implants for minimally invasive surgeries, these products target soft tissue injuries and degenerative conditions across various joints including the shoulder, knee, hip, and smaller joints.
- Arthroscopic Enabling Technologies: Offering fluid management equipment, high-definition cameras, digital image capture systems, scopes, light sources, monitors, and various tissue resection devices, these technologies assist in surgical procedures and visualization inside the joints.
- Ear, Nose, and Throat (ENT) Solutions: Smith & Nephew provides specialized solutions for ENT procedures, enhancing the treatment quality and comfort for patients.
- Advanced Wound Care: The company's advanced wound care products address both acute and chronic wounds, including leg wounds, diabetic ulcers, pressure ulcers, burns, and post-operative wounds. These include:
- Advanced Wound Bioactives: Featuring biologics and other bioactive technologies for debridement and dermal repair/regeneration.
- Regenerative Medicine Products: Offering solutions such as skin, bone graft, and articular cartilage substitutes aimed at facilitating natural healing and regeneration.
- Advanced Wound Devices: Includes traditional and single-use negative pressure wound therapy systems and hydrosurgery systems, which are critical for effective wound management.
